-transparent.png){kind=logo}
BACKGROUND A sensitive, feasible and reproducible marker for renal function is necessary to evaluate the clinical efficacy of enzyme replacement therapy (ERT) in Fabry nephropathy. Serum creatinine has some limitations and cystatin C has been proposed, in other nephropathies, as a useful marker of renal function. The use of cystatin C as a marker of glomerular filtration rate (GFR) was investigated in Fabry patients receiving ERT. METHODS Renal function was evaluated with serum creatinine, serum cystatin C and estimated GFR (through Modification of Diet in Renal Disease [MDRD], Cockcroft-Gault [C&G] and Hoek formulae) in 21 Fabry patients receiving ERT with agalsidase alfa for 3 years and in 13 Fabry patients receiving agalsidase alfa for 4 years. RESULTS During years of ERT while serum creatinine remained stable, cystatin C values showed a significant, increasing trend right from the first year of ERT. CONCLUSIONS In Fabry disease, cystatin C is a sensitive and reliable marker of renal function, and it should be taken into account when evaluating GFR trends during ERT.
Sandro Feriozzi, and
Dominique P Germain, and
Raffaele Di Vito, and
Alain Legrand, and
Roberta Ricci, and
Frédéric Barbey
November 1998,
Scandinavian journal of clinical and laboratory investigation,
Sandro Feriozzi, and
Dominique P Germain, and
Raffaele Di Vito, and
Alain Legrand, and
Roberta Ricci, and
Frédéric Barbey
January 2009,
Nursing standard (Royal College of Nursing (Great Britain) : 1987),
Sandro Feriozzi, and
Dominique P Germain, and
Raffaele Di Vito, and
Alain Legrand, and
Roberta Ricci, and
Frédéric Barbey
May 2013,
Indian journal of nephrology,
Sandro Feriozzi, and
Dominique P Germain, and
Raffaele Di Vito, and
Alain Legrand, and
Roberta Ricci, and
Frédéric Barbey
January 2005,
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
Sandro Feriozzi, and
Dominique P Germain, and
Raffaele Di Vito, and
Alain Legrand, and
Roberta Ricci, and
Frédéric Barbey
November 2005,
Transplantation proceedings,
Sandro Feriozzi, and
Dominique P Germain, and
Raffaele Di Vito, and
Alain Legrand, and
Roberta Ricci, and
Frédéric Barbey
March 2015,
Revista clinica espanola,
Sandro Feriozzi, and
Dominique P Germain, and
Raffaele Di Vito, and
Alain Legrand, and
Roberta Ricci, and
Frédéric Barbey
August 2014,
Diabetes & metabolism journal,
Sandro Feriozzi, and
Dominique P Germain, and
Raffaele Di Vito, and
Alain Legrand, and
Roberta Ricci, and
Frédéric Barbey
January 2005,
Kidney & blood pressure research,
Sandro Feriozzi, and
Dominique P Germain, and
Raffaele Di Vito, and
Alain Legrand, and
Roberta Ricci, and
Frédéric Barbey
February 2006,
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
Sandro Feriozzi, and
Dominique P Germain, and
Raffaele Di Vito, and
Alain Legrand, and
Roberta Ricci, and
Frédéric Barbey
November 2008,
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
